ReviewTheScientificWorldJournal2014
Why are we failing to implement imaging studies with radiolabelled new molecular entities in early oncology drug development?
Azeem Saleem et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it